Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy

References

• Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506–11
   PubMed Web of Science ®Google Scholar
• Heit JA. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001; 12:81–7
   PubMed Web of Science ®Google Scholar
• Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004;147:3–15
   PubMed Web of Science ®Google Scholar
• Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002;108:3–13
   PubMed Web of Science ®Google Scholar
• American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001
   Google Scholar
• Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):204S–33
   Google Scholar
• Guyatt G, Schunemann HJ, Cook D, et al. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):179S–87
   Google Scholar
• Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am 2001;85:1109–16
   PubMed Web of Science ®Google Scholar
• Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484–8
   PubMed Web of Science ®Google Scholar
• Landefeld CS, Cook EF, Flatley M, et al. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82:703–13
   PubMed Web of Science ®Google Scholar
• Dotan ZA, Mor Y, Leibovitch I, et al. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 2002;168:610–3
   PubMed Web of Science ®Google Scholar
• Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003;163:901–8
   PubMed Web of Science ®Google Scholar
• Omran H, Hammerstingl C, Schmidt H, et al. A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 2003;90:267–71
   PubMed Web of Science ®Google Scholar
• Tsilimingras K, Grasso-Correnti N, Fanikos J, et al. Initiation of anticoagulation after cardiac surgery: a prospective cohort study of efficacy, safety and cost with low molecular weight heparin bridging in lieu of continuous intravenous unfractionated heparin. J Am Coll Cardiol 2002;39(Suppl 2):428A [abstract]
   Google Scholar
• Mehra P, Cottrell DA, Bestgen SC, et al. Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000;58:198–202
   PubMed Web of Science ®Google Scholar
• Alexander R, Ferretti AC, Sorensen JR. Stop the nonsense not the anticoagulants: a matter of life and death. NY State Dent J 2002;68:24–6
   Google Scholar
• Gerson LB, Gage BF, Owens DK, et al. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Am J Gastroenterol 2000;95:1717–24
   PubMed Web of Science ®Google Scholar
• McCormack P, Simcock PR, Tullo AB. Management of the anticoagulated patient for ophthalmic surgery. Eye 1993;7: 749–50
   Google Scholar
• Santamaria MA, Mateo J, Pujol N, et al. Management of anticoagulation in patients who require colonoscopy or gastroscopy: safety and efficacy of sodic bemiparin (Hibor®). Blood 2004;104:4060 [abstract]
   Google Scholar
• Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998;158:1610–6
   PubMed Web of Science ®Google Scholar
• Russo G, Corso LD, Biasiolo A, et al. Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures. Clin Appl Thromb Hemost 2000;6:90–3
   PubMed Web of Science ®Google Scholar
• Johnson-Leong C, Rada RE. The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy. J Am Dent Assoc 2002;133:1083–7
   Google Scholar
• Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000;38:124–6
   PubMed Web of Science ®Google Scholar
• Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003;139:893–900
   Google Scholar
• Schmidt B, Schellong S. Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism. Med Klin (Munich) 2003;98:447–52 [in German]
   Google Scholar
• Watts SA, Gibbs NM. Outpatient management of the chronically anticoagulated patient for elective surgery. Anaesth Intensive Care 2003;31:145–54
   PubMed Web of Science ®Google Scholar
• Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458–62
   PubMed Web of Science ®Google Scholar
• Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of prosthetic valve anticoagulation. Mayo Clin Proc 1998;73:665–80
   PubMed Web of Science ®Google Scholar
• Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191–6
   Google Scholar
• Elkayam U, Singh H, Irani A, et al. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004;9:107–15
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl): 627S–44
   Google Scholar
• The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998;279:1273–7
   PubMed Web of Science ®Google Scholar
• EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342: 1255–62
   Google Scholar
• Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285: 2864–70
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231–65
   PubMed Web of Science ®Google Scholar
• Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):483S–512
   Google Scholar
• Salem DN, Stein PD, Al Ahmad A, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):457S–82
   Google Scholar
• Longstreth WT Jr, Bernick C, Fitzpatrick A, et al. Frequency and predictors of stroke death in 5888 participants in the Cardiovascular Health Study. Neurology 2001;56:368–75
   PubMed Web of Science ®Google Scholar
• Douketis JD, Crowther MA, Cherian SS, et al. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999;116:1240–6
   PubMed Web of Science ®Google Scholar
• Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978;96:163–5
   Google Scholar
• Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688–98
   PubMed Web of Science ®Google Scholar
• Heuts LM, Arvik BM, Cender DE. LMWH for perioperative anticoagulation in patients on chronic warfarin therapy. Ann Pharmacother 2004;38:1065–9
   Google Scholar
• Berdagué P, Boneu B, Soula P, et al. Usefulness of low-molecular-weight heparins during post-operative period in mitral mechanical valve replacement: clinical ischaemic and haemorrhagic complications in 110 cases. Eur Heart J 1998;19(Suppl):534 [abstract]
   Google Scholar
• Ferreira I, Dos L, Tornos P, et al. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89:527–30
   PubMed Web of Science ®Google Scholar
• Galla JM, Fuhs BE. Outpatient anticoagulation protocol for mechanical valve recipients undergoing non-cardiac surgery. J Am Coll Cardiol 2000;35(Suppl A):531A [abstract]
   Google Scholar
• Turpie AG, Douketis JD. Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who require temporary interruption of warfarin because of surgery or an invasive procedure. Blood 2004;104:202a [abstract]
   Google Scholar
• Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110:1658–63
   PubMed Web of Science ®Google Scholar
• Tinmouth AH, Morrow BH, Cruickshank MK, et al. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001;35: 669–74
   PubMed Web of Science ®Google Scholar
• Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004;164: 1319–26
   Google Scholar
• Omran H, Hammerstingl C, Schmidt H, et al. Periinterventionelles Management bei oral antikoagulierten Patienten. Hämostaseologie 2005;XX:L6 [abstract]
   Google Scholar
• Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84:478–80, A10
   Google Scholar
• Wilson S, Morgan J, Gray L, et al. A model for perioperative outpatient management of anticoagulation in high-risk patients: an evaluation of effectiveness and safety. Can J Hosp Pharm 2001;54:269–77
   Google Scholar
• Hammerstingl C, Schlang G, Bernhardt P, et al. Einsetzbarkeit niedermolekularer Heparine bei Umstellung einer oralen Antikoagulation vor Interventionen mit erhoehtem Blutungsrisiko: Das ‘Bonn-register’ – Erfahrungen mit 200 patienten. Z Kardiol 2004;93(S):281–2
   Google Scholar
• Dunn AS, Spyropoulos AC, Sirko SP, et al. Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy: a multicentre cohort study. Blood 2004;104:1761 [abstract]
   Google Scholar
• Nutescu E, Helgason C. Outpatient dalteparin peri-procedure bridge therapy in patients maintained on long term warfarin. Stroke 2001;32:328–9
   Web of Science ®Google Scholar
• Johnson JA, Turpie AG. Temporary discontinuation of oral anticoagulants: role of low molecular weight heparin. Thromb Haemost 2001;85:P2323 [abstract]
   Google Scholar
• Baudo F, Ghirarduzzi A, Molinatti M, et al. Low molecular weight heparin during surgery in patients on long term oral anticoagulant treatment (OAT): a prospective observational study. Blood 2004;104:4063 [abstract]
   Google Scholar
• Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;101:1083–6
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006:4;1246–52
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Dunn AS, Turpie AG, et al. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical heart valves on long term oral anticoagulants: results from the REGIMEN registry. J Am Coll Cardiol 2005;45(Suppl A):352A [abstract]
   Google Scholar
• Fanikos J, Tsilimingras K, Kucher N, et al. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004;93:247–50
   PubMed Web of Science ®Google Scholar
• Amorosi SL, Tsilimingras K, Thompson D, et al. Cost analysis of ‘bridging therapy’ with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol 2004;93:509–11
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Frost FJ, Hurley JS, et al. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest 2004;125:1642–50
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Jenkins P, Bornikova L. A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation. Pharmacotherapy 2004;24:649–58
   Google Scholar
• Smith LK, McKee BD, Schroeder DP. Cost effectiveness and safety of outpatient enoxaparin bridge therapy. Chest 1999;116(Suppl 2):360S
   Google Scholar
• Goldstein JL, Larson LR, Yamashita BD, et al. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study. Am J Gastroenterol 2001;96:2360–6
   PubMed Web of Science ®Google Scholar
• Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl): 429S–56
   Google Scholar
• Larson BJG, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2005;127:922–7
   Google Scholar